Sumitomo Dainippon Price To Earning vs. Net Income

DNPUFDelisted Stock  USD 4.37  0.00  0.00%   
Considering Sumitomo Dainippon's profitability and operating efficiency indicators, Sumitomo Dainippon Pharma may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Sumitomo Dainippon's ability to earn profits and add value for shareholders.
For Sumitomo Dainippon profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sumitomo Dainippon to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sumitomo Dainippon Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sumitomo Dainippon's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sumitomo Dainippon Pharma over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Please note, there is a significant difference between Sumitomo Dainippon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sumitomo Dainippon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sumitomo Dainippon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sumitomo Dainippon Pharma Net Income vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Sumitomo Dainippon's current stock value. Our valuation model uses many indicators to compare Sumitomo Dainippon value to that of its competitors to determine the firm's financial worth.
Sumitomo Dainippon Pharma is rated below average in price to earning category among its peers. It is one of the top stocks in net income category among its peers making up about  11,777,244,259  of Net Income per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sumitomo Dainippon's earnings, one of the primary drivers of an investment's value.

Sumitomo Net Income vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Sumitomo Dainippon

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
4.79 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Sumitomo Dainippon

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
56.41 B
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Sumitomo Net Income Comparison

Sumitomo Dainippon is currently under evaluation in net income category among its peers.

Sumitomo Dainippon Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Sumitomo Dainippon, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sumitomo Dainippon will eventually generate negative long term returns. The profitability progress is the general direction of Sumitomo Dainippon's change in net profit over the period of time. It can combine multiple indicators of Sumitomo Dainippon, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people.

Sumitomo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Sumitomo Dainippon. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sumitomo Dainippon position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sumitomo Dainippon's important profitability drivers and their relationship over time.

Use Sumitomo Dainippon in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sumitomo Dainippon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will appreciate offsetting losses from the drop in the long position's value.

Sumitomo Dainippon Pair Trading

Sumitomo Dainippon Pharma Pair Trading Analysis

The ability to find closely correlated positions to Sumitomo Dainippon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sumitomo Dainippon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sumitomo Dainippon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sumitomo Dainippon Pharma to buy it.
The correlation of Sumitomo Dainippon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sumitomo Dainippon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sumitomo Dainippon Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sumitomo Dainippon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sumitomo Dainippon position

In addition to having Sumitomo Dainippon in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Market Neutral Funds Thematic Idea Now

Market Neutral Funds
Market Neutral Funds Theme
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Sumitomo Pink Sheet

If you are still planning to invest in Sumitomo Dainippon Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sumitomo Dainippon's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets